Prestige 5 1 ml/Dose 10 ml
Key product information
Important product information
Review product information, ingredients, storage, warnings, and other important details before ordering.
Overview
Read the product description and usage details.
Overview
A combination of inactivated, concentrated, adjuvanted, tissue culture origin equine encephalomyelitis viruses (Eastern and Western), equine herpesviruses types 1 and 4 (EHV-1 and EHV-4), equine influenza virus type H3N8 strains (EIV A/Equine 2/ Kentucky/93 American, EIV A/Equine 2/Kentucky/02 American and EIV A/Equine 2/Newmarket/2/93 Eurasian) and tetanus toxoid. Intervet serological data suggest influenza cross protection against certain U.S. and European strains, including Kentucky 91, 93, 99, 02, Ohio 03, Newmarket/1/93, Newmarket/2/93, Suffolk 89 and South Africa 03.
Product Details
| Approved For | Horse |
| Therapeutic Use | Vaccine |
| Form | Suspension |
| Route of Administration | Intramuscular |
| Strength / Concentration | 1 ml/Dose ml/Dose |
| Pack Size | 10 ml |
Safety & Storage
Storage: Refrigerated
Specifications
Review available public product specifications and handling details.
Basic Information
| Brand | Merck |
|---|---|
| Strength | 1 ml/Dose ml/Dose |
| Pack Size | 10 ml |
Storage & Shipping
| Shipping Weight | 0.016 kg |
|---|---|
| Storage Conditions | Refrigerated |
Important Notice
Product information is provided for reference only and does not replace veterinary advice. Always follow your veterinarian’s direction for prescription products.
